23/02/201826/01/2024 L-DOS47 US Phase I Study Presentation at the IASLC 18th Annual Target Therapies of Lung Cancer Meeting admin 0 Comments
22/02/201826/01/2024 Helix BioPharma Corp. Appoints Deloitte as Strategic Advisor to Explore Partnering and Licensing Opportunities admin 0 Comments
06/02/201826/01/2024 Helix BioPharma Corp and Helix Immuno-Oncology to present at AACR in Chicago admin 0 Comments